Sort
48,018 grants matching “immunotherapy”
High-efficiency microfluidic cell fusion for dendritic cell/tumor cell vaccine production
$428,524Joel Voldman · Massachusetts Institute Of Technology · R21 · FY2021 · CA
Molecular Mechanisms in Gastrointestinal Stromal Tumor
$428,500Ronald P Dematteo · Sloan-Kettering Inst Can Research · R01 · FY2016 · CA
CLINICAL TRIALS OF ALLOGENEIC STEM CELL TRANSPLANT IN LYMPHOHEMATOPOIETIC DISORDE
$428,498Richard J O'Reilly · Sloan-Kettering Inst Can Research · P01 · FY2008 · CA
The DARC side of Breast Cancer Disparities - African Ancestry and Cancer- Related Immune Response
$428,497Melissa B Davis · Morehouse School Of Medicine · R01 · FY2025 · CA
Targeting Transcriptional Regulators for Immunotherapy of Acute Myeloid Leukemia
$428,441Marcin Kortylewski · Beckman Research Institute/City Of Hope · R01 · FY2017 · CA
SynerGel: A Novel Tumor Microenvironment-Modulating Hydrogel for Local Immunotherapy
$428,440Simon Young · University Of Texas Hlth Sci Ctr Houston · R01 · FY2021 · DE
Identification of cancer neoepitope-specific T cells using novel high-throughput hydrogel based platforms
$428,438Jonathan P Schneck · Johns Hopkins University · R33 · FY2024 · CA
Enhancing Tumor Antigen Presentation with Complement Targeted Nanoparticles
$428,365Max Peter Kullberg · University Of Alaska Anchorage · R15 · FY2018 · CA
Lymphoid residency of Tcf-1+ CD8+ T cells during tumor vaccine responses
$428,354Nu Zhang · University Of Texas Hlth Science Center · R01 · FY2025 · AI
Project 2: Understanding the Cellular Origins of Melanoma
$428,337Anand K Ganesan · University Of California-Irvine · U54 · FY2022 · CA
Enhanced imaging and treatment of aggressive subtypes of prostate cancer
$428,295Martin G Pomper · Ut Southwestern Medical Center · R01 · FY2025 · CA
AUTOIMMUNITY: TREATMENT BY COSTIMULATORY SIGNAL BLOCKADE
$428,260Brigham And Women'S Hospital · U19 · FY2002 · AI
Multiple Approaches to Abeta Vaccination in Animal Models
$428,214David Hastings Cribbs · University Of California-Irvine · R01 · FY2010 · AG
An innovative integrated computational framework using gene signatures for patient stratification
$428,162Chao Cheng · Baylor College Of Medicine · R01 · FY2024 · CA
Targeting NQO1+ tumor to trigger innate and adaptive immunity
$427,984Xiumei Huang · Indiana University Indianapolis · R01 · FY2024 · CA
Role of type 2 Innate Lymphoid Cells (ILC2s) in optic neuritis
$427,983Homayon Ghiasi · Cedars-Sinai Medical Center · R01 · FY2021 · EY
Role of type 2 Innate Lymphoid Cells (ILC2s) in optic neuritis
$427,982Homayon Ghiasi · Cedars-Sinai Medical Center · R01 · FY2022 · EY
PATHOBIOLOGY OF ACUTE AND CHRONIC HEPADNAVIRUS INFECTIONS
$427,975Fox Chase Cancer Center · U19 · FY2000 · CA
Role of type 2 immune response in pancreatic cancer tumorigenesis
$427,908Prasenjit Dey · Roswell Park Cancer Institute Corp · R01 · FY2021 · CA
Heterlogous Prime and Boost Vaccine Strategies
$427,897Duke University · P01 · FY2004 · CA
Liquid biopsy of the lung to profile lung cancer
$427,888Viswam Siva Nair · Fred Hutchinson Cancer Research Center · U01 · FY2020 · CA
Targeting Tumor Initiating Cell in Undifferentiated Pleomorphic Sarcoma
$427,850Benjamin Aaron Alman · Duke University · R01 · FY2014 · CA
Breathing, Full Volume Pulmonary Deposition Model to Transform Development of Aerosol Therapeutics
$427,811Catherine A Fromen · University Of Delaware · R21 · FY2025 · TR
Synthetic Studies Related to Cancer Research/Treatment
$427,796Paul Wender · Stanford University · R01 · FY2022 · CA
Investigating and modeling MYD88L265P and co-occurring mutations in mature B-cell malignancies
$427,785Ruben D Carrasco · Dana-Farber Cancer Inst · R01 · FY2024 · CA